Tyson Christensen, MD
Orthopaedic Surgery · Farmington, NMNPI 1326454125
Payments from drug & device makers
What this record shows
This record is dominated by education: $6,624 of the $7,379 with a category attached, or 89.8%. Smith+Nephew accounts for 90.6% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2020 at $3,665 and has fallen 97.4% since, to $96 in 2025.
Across 20 payments — averaging $368.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$7K
- Arthrex$341
- Zimmer Biomet$96
- Orthalign Inc$66
- Vericel Corporation$41
- Stryker$35
- plus $117 from 6 others
What the payments were for
- Travel & lodging$3415%
- Food & beverage$4146%
- Education$6,62490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 5 | $6,683 |
| Arthrex | 2 | $341 |
| Zimmer Biomet | 2 | $96 |
| Orthalign Inc | 1 | $66 |
| Vericel Corporation | 2 | $41 |
| Stryker | 1 | $35 |
| Amgen | 2 | $30 |
| Heron Therapeutics, Inc. | 1 | $22 |
| KCI USA, Inc. | 1 | $17 |
| Ferring Pharmaceuticals Inc. | 1 | $17 |
| Johnson & Johnson | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Firstpass$124
How this compares
$7,379 in reported general payments places this provider in the 70th percentile of 107 orthopaedic surgery providers in New Mexico.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 29 | $1,760 |
| Naproxen | 67 | $463 |
| Meloxicam | 126 | $385 |
| Oxycodone Hcl | 64 | $331 |
| Gabapentin | 73 | $298 |
| Famotidine | 51 | $215 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $161 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $116 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Farmington
- Jonathan HancockFarmington$7K
- Jaren LagrecaFarmington$6K
- Deana MercerAlbuquerque$901K
- Dan GuttmanTaos$530K
- David ChafeyAlbuquerque$108K
- Heather MenzerAlbuquerque$61K
- Ernesto Otero LopezAlbuquerque$50K
- Rick GehlertAlbuquerque$46K
- Jeffrey BeckenbaughAlbuquerque$46K
- Luciano RamiresTaos$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.